Medicine and Dentistry
T Cell
100%
Alendronic Acid
83%
In Vitro
80%
Immunotherapy
78%
Neoplasm
62%
Combination Therapy
46%
Liposome
32%
Cells
31%
Obstetric Delivery
31%
Receptor
31%
Biodistribution
31%
Nitrogen
30%
Bisphosphonate
30%
Organ
27%
Sensitization
27%
Integrin Receptor
26%
Tumor Model
25%
Hepatitis B Virus
25%
Virus Core
25%
Gamma Urogastrone
25%
Epidermal Growth Factor Receptor 2
25%
Restylane
25%
Nuclear Imaging
25%
Clinical Study
19%
Tumor Progression
17%
Enalapril Maleate
16%
Gemcitabine
15%
Cancer Cell
13%
Lung
12%
Zoledronic Acid
11%
Metastatic Lung Tumor
9%
Intravenous Drug Administration
9%
Cancer Therapy
7%
Solid Malignant Neoplasm
7%
Nodular Melanoma
6%
Injection
5%
Blood
5%
Ligand
5%
Monotherapy
5%
Therapeutic Procedure
5%
Drug Delivery Vehicle
5%
Receptor Binding
5%
Intraperitoneal Drug Administration
5%
Chlormethine
5%
Biocompatibility
5%
Cell Line
5%
Chemotherapeutic Agent
5%
Drug
5%
Pharmacology, Toxicology and Pharmaceutical Science
Immunotherapy
75%
Neoplasm
70%
Mouse
61%
Alendronic Acid
58%
Receptor
31%
Bisphosphonic Acid Derivative
30%
Nitrogen
30%
Malignant Neoplasm
29%
Liposome
28%
Integrin Receptor
26%
Hyaluronic Acid
25%
Hepatitis B Virus
25%
Hedgehog
25%
Epidermal Growth Factor Receptor 2
25%
Gamma Urogastrone
25%
Gemcitabine
15%
Tumor Growth
13%
Zoledronic Acid
11%
Solid Malignant Neoplasm
10%
Biodistribution
9%
Nitrogen Mustard
8%
Mouse Model
7%
Cytotoxicity
7%
Monotherapy
5%
Ligand
5%
Drug
5%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
30%
Mouse
25%
CD44
25%
Hyaluronic Acid
25%
Solvent
25%
Click
25%
MUC1
25%
Epidermal Growth Factor Receptor
25%
Virus Core
25%
Hepatitis B Virus
25%
Gemcitabine
15%
Thiol
12%
Fourier Transform Infrared Spectroscopy
12%
Antibody
12%
Fluorescence Microscopy
12%
Confocal Laser Scanning Microscopy
12%
Immunoglobulin G
12%
Thermogravimetric Analysis
12%
Flow Cytometry
12%
Mucin
12%
Atomic Force Microscopy
12%
Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis
12%
Copper
12%
Cycloaddition
12%
Electric Potential
7%
Peptide Sequence
5%
Development
5%